
KRAS Mutations as Prognostic and Predictive Markers in Non–Small Cell Lung Cancer
Keywords: گیرنده فاکتور رشد اپیدرمال; Non–small-cell lung cancer; Epidermal growth factor receptor; KRAS; Mutations; Erlotinib; Gefitinib; Cetuximab